PT - JOURNAL ARTICLE AU - Vinall, Maria ED - Sharifi, Mohsen TI - Moderate PE Treated with Thrombolysis (MOPETT Study) DP - 2012 Jun 01 TA - MD Conference Express PG - 13--14 VI - 12 IP - 4 4099 - http://mdc.sagepub.com/content/12/4/13.2.short 4100 - http://mdc.sagepub.com/content/12/4/13.2.full AB - Pulmonary embolism (PE) is one of the most common preventable causes of death (responsible for >100,000 deaths annually) and the third leading cause of cardiovascular mortality. New data from the Moderate Pulmonary Embolism Treated with Thrombolysis [MOPETT] study suggest that moderate PE patients may be managed with reduced-dose issue plasminogen activator and modified anticoagulation.